Skip to main content
Erschienen in: World Journal of Urology 6/2013

01.12.2013 | Original Article

Minimally invasive percutaneous nephrolithotomy: an alternative to retrograde intrarenal surgery and shockwave lithotripsy

verfasst von: Stephan Kruck, Aristoteles G. Anastasiadis, Thomas R. W. Herrmann, Ute Walcher, Mohamed F. Abdelhafez, André P. Nicklas, Lillian Hölzle, David Schilling, Jens Bedke, Arnulf Stenzl, Udo Nagele

Erschienen in: World Journal of Urology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

There is a lack of studies comparing shock wave lithotripsy (SWL), retrograde intrarenal surgery (RIRS) and minimally invasive percutaneous nephrolithotomy (MIP) in renal stone treatment. This study compared treatment outcome, stone-free rate (SFR) and stone-free survival (SFS) with regard to stone size and localization.

Methods

This analysis included 482 first-time-treated patients in the period 2001–2007. Detailed clinical information, stone analysis and metabolic evaluation were evaluated retrospectively. Outcome, SFR and SFS were analyzed with regard to size (<1 vs. ≥1 cm) and localization (lower vs. non-lower pole).

Results

Higher SFRs in lower and non-lower pole stones ≥1 cm were confirmed for RIRS and MIP (p < 0.0001). A regression model confirmed a higher risk of non-lower pole stone persistence for SWL versus RIRS (OR: 2.27, p = 0.034, SWL vs. MIP (OR: 3.23, p = 0.009) and larger stone burden ≥1 versus <1 cm (OR: 2.43, p = 0.006). In accordance, a higher risk of residual stones was found in the lower pole for SWL versus RIRS (OR: 2.67, p = 0.009), SWL versus MIP (OR: 4.75, p < 0.0001) and stones ≥1 cm versus <1 cm (OR: 3.02, p = 0.0006). In RIRS and MIP patients, more complications, stenting, prolonged disability, need/duration of hospitalization and analgesia were noticed (p < 0.05). Overall SFS increased from SWL, RIRS, to MIP (p < 0.001). SWL showed lower SFS for non-lower pole (p = 0.006) and lower pole stones (p = 0.007).

Conclusions

RIRS and MIP were shown to have higher stone-free rates and SFS compared to SWL. The price for better outcome was higher, considering tolerable complication rates. Despite larger preoperative stone burden, MIP achieved high and long-term treatment success.
Literatur
1.
Zurück zum Zitat Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96PubMed Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96PubMed
4.
Zurück zum Zitat Lahme S, Bichler KH, Strohmaier WL, Götz T (2001) Minimally invasive PCNL in patients with renal pelvic and calyceal stones. Eur Urol 40(6):619–624PubMedCrossRef Lahme S, Bichler KH, Strohmaier WL, Götz T (2001) Minimally invasive PCNL in patients with renal pelvic and calyceal stones. Eur Urol 40(6):619–624PubMedCrossRef
5.
Zurück zum Zitat Nagele U, Schilling D, Anastasiadis AG, Walcher U, Sievert KD, Merseburger AS, Kuczyk M, Stenzl A (2008) Minimally invasive percutaneous nephrolitholapaxy (MIP). Der Urologe Aus A 47(9):1066, 1068–1073. doi:10.1007/s00120-008-1814-2 Nagele U, Schilling D, Anastasiadis AG, Walcher U, Sievert KD, Merseburger AS, Kuczyk M, Stenzl A (2008) Minimally invasive percutaneous nephrolitholapaxy (MIP). Der Urologe Aus A 47(9):1066, 1068–1073. doi:10.​1007/​s00120-008-1814-2
6.
Zurück zum Zitat Nagele U, Horstmann M, Sievert KD, Kuczyk MA, Walcher U, Hennenlotter J, Stenzl A, Anastasiadis AG (2007) A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in vitro pressure-measurement and microscopic study. J Endourol Endourol Soc 21(9):1113–1116. doi:10.1089/end.2006.0230 CrossRef Nagele U, Horstmann M, Sievert KD, Kuczyk MA, Walcher U, Hennenlotter J, Stenzl A, Anastasiadis AG (2007) A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in vitro pressure-measurement and microscopic study. J Endourol Endourol Soc 21(9):1113–1116. doi:10.​1089/​end.​2006.​0230 CrossRef
7.
Zurück zum Zitat Nagele U, Schilling D, Sievert KD, Stenzl A, Kuczyk M (2008) Management of lower-pole stones of 0.8 to 1.5 cm maximal diameter by the minimally invasive percutaneous approach. J Endourol Endourol Soc 22(9):1851–1853; (discussion 1857). doi:10.1089/end.2008.9791 Nagele U, Schilling D, Sievert KD, Stenzl A, Kuczyk M (2008) Management of lower-pole stones of 0.8 to 1.5 cm maximal diameter by the minimally invasive percutaneous approach. J Endourol Endourol Soc 22(9):1851–1853; (discussion 1857). doi:10.​1089/​end.​2008.​9791
10.
Zurück zum Zitat Albala DM, Assimos DG, Clayman RV, Denstedt JD, Grasso M, Gutierrez-Aceves J, Kahn RI, Leveillee RJ, Lingeman JE, Macaluso JN Jr, Munch LC, Nakada SY, Newman RC, Pearle MS, Preminger GM, Teichman J, Woods JR (2001) Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis-initial results. J Urol 166(6):2072–2080. doi:10.1097/00005392-200112000-00014 PubMedCrossRef Albala DM, Assimos DG, Clayman RV, Denstedt JD, Grasso M, Gutierrez-Aceves J, Kahn RI, Leveillee RJ, Lingeman JE, Macaluso JN Jr, Munch LC, Nakada SY, Newman RC, Pearle MS, Preminger GM, Teichman J, Woods JR (2001) Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis-initial results. J Urol 166(6):2072–2080. doi:10.​1097/​00005392-200112000-00014 PubMedCrossRef
11.
Zurück zum Zitat Pearle MS, Lingeman JE, Leveillee R, Kuo R, Preminger GM, Nadler RB, Macaluso J, Monga M, Kumar U, Dushinski J, Albala DM, Wolf JS Jr, Assimos D, Fabrizio M, Munch LC, Nakada SY, Auge B, Honey J, Ogan K, Pattaras J, McDougall EM, Averch TD, Turk T, Pietrow P, Watkins S (2008) Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol 179(5 Suppl):S69–S73. doi:10.1016/j.juro.2008.03.140 Pearle MS, Lingeman JE, Leveillee R, Kuo R, Preminger GM, Nadler RB, Macaluso J, Monga M, Kumar U, Dushinski J, Albala DM, Wolf JS Jr, Assimos D, Fabrizio M, Munch LC, Nakada SY, Auge B, Honey J, Ogan K, Pattaras J, McDougall EM, Averch TD, Turk T, Pietrow P, Watkins S (2008) Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol 179(5 Suppl):S69–S73. doi:10.​1016/​j.​juro.​2008.​03.​140
13.
Zurück zum Zitat Pevzner M, Stisser B, Luskin J, Yeamans J, Cheng-Lucey M, Pahira J (2011) Alternative management of complex renal stones. Int Urol Nephrol 43(3):631–638. doi:10.1007/s11255-010-9880-y Pevzner M, Stisser B, Luskin J, Yeamans J, Cheng-Lucey M, Pahira J (2011) Alternative management of complex renal stones. Int Urol Nephrol 43(3):631–638. doi:10.​1007/​s11255-010-9880-y
17.
Zurück zum Zitat Bozkurt OF, Resorlu B, Yildiz Y, Can CE, Unsal A (2011) Retrograde intrarenal surgery versus percutaneous nephrolithotomy in the management of lower-pole renal stones with a diameter of 15 to 20 mm. J Endourol 25(7):1131–1135. doi:10.1089/end.2010.0737 PubMedCrossRef Bozkurt OF, Resorlu B, Yildiz Y, Can CE, Unsal A (2011) Retrograde intrarenal surgery versus percutaneous nephrolithotomy in the management of lower-pole renal stones with a diameter of 15 to 20 mm. J Endourol 25(7):1131–1135. doi:10.​1089/​end.​2010.​0737 PubMedCrossRef
19.
Zurück zum Zitat Labate G, Modi P, Timoney A, Cormio L, Zhang X, Louie M, Grabe M, de la Rosette On Behalf Of The Croes Pcnl Study Group J (2011) The percutaneous nephrolithotomy global study: classification of complications. J Endourol 25(8):1275–1280. doi:10.1089/end.2011.0067 Labate G, Modi P, Timoney A, Cormio L, Zhang X, Louie M, Grabe M, de la Rosette On Behalf Of The Croes Pcnl Study Group J (2011) The percutaneous nephrolithotomy global study: classification of complications. J Endourol 25(8):1275–1280. doi:10.​1089/​end.​2011.​0067
20.
Zurück zum Zitat Tan YM, Yip SK, Chong TW, Wong MY, Cheng C, Foo KT (2002) Clinical experience and results of ESWL treatment for 3,093 urinary calculi with the Storz Modulith SL 20 lithotripter at the Singapore general hospital. Scand J Urol Nephrol 36(5):363–367. doi:10.1080/003655902320783872 PubMedCrossRef Tan YM, Yip SK, Chong TW, Wong MY, Cheng C, Foo KT (2002) Clinical experience and results of ESWL treatment for 3,093 urinary calculi with the Storz Modulith SL 20 lithotripter at the Singapore general hospital. Scand J Urol Nephrol 36(5):363–367. doi:10.​1080/​0036559023207838​72 PubMedCrossRef
21.
Zurück zum Zitat Nagele U, Schilling D, Anastasiadis AG, Walcher U, Sievert KD, Merseburger AS, Kuczyk M (1066) Stenzl A (2008) [Minimally invasive percutaneous nephrolitholapaxy (MIP)]. Urol A 47(9):1068–1073. doi:10.1007/s00120-008-1814-2 Nagele U, Schilling D, Anastasiadis AG, Walcher U, Sievert KD, Merseburger AS, Kuczyk M (1066) Stenzl A (2008) [Minimally invasive percutaneous nephrolitholapaxy (MIP)]. Urol A 47(9):1068–1073. doi:10.​1007/​s00120-008-1814-2
22.
Zurück zum Zitat Mishra S, Sharma R, Garg C, Kurien A, Sabnis R, Desai M (2011) Prospective comparative study of Miniperc and standard PNL for treatment of 1 to 2 cm size renal stone. BJU Int 108(6):896–899; discussion 899-900. doi:10.1111/j.1464-410X.2010.09936.x Mishra S, Sharma R, Garg C, Kurien A, Sabnis R, Desai M (2011) Prospective comparative study of Miniperc and standard PNL for treatment of 1 to 2 cm size renal stone. BJU Int 108(6):896–899; discussion 899-900. doi:10.​1111/​j.​1464-410X.​2010.​09936.​x
23.
Zurück zum Zitat Lahme S, Zimmermanns V, Hochmuth A, Janitzki V (2008) Minimally invasive PCNL (mini-perc). Alternative treatment modality or replacement of conventional PCNL?. Der Urologe Ausg A 47(5):563–568. doi:10.1007/s00120-008-1708-3 Lahme S, Zimmermanns V, Hochmuth A, Janitzki V (2008) Minimally invasive PCNL (mini-perc). Alternative treatment modality or replacement of conventional PCNL?. Der Urologe Ausg A 47(5):563–568. doi:10.​1007/​s00120-008-1708-3
24.
Zurück zum Zitat Schilling D, Gakis G, Walcher U, Stenzl A, Nagele U (2011) The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert. World J Urol 29(6):749–753. doi:10.1007/s00345-010-0553-3 PubMedCrossRef Schilling D, Gakis G, Walcher U, Stenzl A, Nagele U (2011) The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert. World J Urol 29(6):749–753. doi:10.​1007/​s00345-010-0553-3 PubMedCrossRef
25.
26.
Zurück zum Zitat Abe T, Akakura K, Kawaguchi M, Ueda T, Ichikawa T, Ito H, Nozumi K, Suzuki K (2005) Outcomes of shockwave lithotripsy for upper urinary-tract stones: a large-scale study at a single institution. J Endourol 19(7):768–773. doi:10.1089/end.2005.19.768 PubMedCrossRef Abe T, Akakura K, Kawaguchi M, Ueda T, Ichikawa T, Ito H, Nozumi K, Suzuki K (2005) Outcomes of shockwave lithotripsy for upper urinary-tract stones: a large-scale study at a single institution. J Endourol 19(7):768–773. doi:10.​1089/​end.​2005.​19.​768 PubMedCrossRef
27.
Zurück zum Zitat Wiesenthal JD, Ghiculete D, Dah RJ, Pace KT (2011) A comparison of treatment modalities for renal calculi between 100 and 300 mm2: are shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy equivalent? J Endourol 25(3):481–485. doi:10.1089/end.2010.0208 PubMedCrossRef Wiesenthal JD, Ghiculete D, Dah RJ, Pace KT (2011) A comparison of treatment modalities for renal calculi between 100 and 300 mm2: are shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy equivalent? J Endourol 25(3):481–485. doi:10.​1089/​end.​2010.​0208 PubMedCrossRef
28.
Zurück zum Zitat Srisubat A, Potisat S, Lojanapiwat B, Setthawong V, Laopaiboon M (2009) Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones. Cochrane Database Syst Rev (4):CD007044. doi:10.1002/14651858.CD007044.pub2 Srisubat A, Potisat S, Lojanapiwat B, Setthawong V, Laopaiboon M (2009) Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones. Cochrane Database Syst Rev (4):CD007044. doi:10.​1002/​14651858.​CD007044.​pub2
Metadaten
Titel
Minimally invasive percutaneous nephrolithotomy: an alternative to retrograde intrarenal surgery and shockwave lithotripsy
verfasst von
Stephan Kruck
Aristoteles G. Anastasiadis
Thomas R. W. Herrmann
Ute Walcher
Mohamed F. Abdelhafez
André P. Nicklas
Lillian Hölzle
David Schilling
Jens Bedke
Arnulf Stenzl
Udo Nagele
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 6/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-0962-6

Weitere Artikel der Ausgabe 6/2013

World Journal of Urology 6/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.